MIT-Harvard Center of Cancer Nanotechnology
Massachusetts Institute of Technology and Harvard University CCNE

• Center Home
• Overview
• Projects
• Cores
• Investigators
• Publications

The overall goal of this U54 application is to create and support a highly multidisciplinary team of chemists, biologists, engineers, and physicians to develop and rapidly translate new nanotechnologies to better diagnose and treat cancer. » Read More

Center Investigators

Robert Langer, Ph.D.
Principal Investigator

Ralph Weissleder, M.D., Ph.D.
Principal Investigator

[+] More Investigators

December 4, 2006
MIT implant measures tumor growth, treatment
View press release

View all Alliance News

Projects

• Project 1: Targeted Polymeric Nanoparticles for Cancer Therapeutic Applications
• Project 2: Treatment of Cancer with siRNA Delivered by Nanoparticles
• Project 3: Development of Clinical-Grade, Targeted Magnetic Nanoparticles
• Project 4: Discrete Sensor Devices for Determining Cancer Targets
• Project 5: Novel Semiconducting Nanocrystals for Cancer Detection

Cores

• Administration Core
• Toxicity Core
• Mouse Models Core